J&J Shot Loses Antibody Protection Against Omicron in Study – BloombergQuint

Bloomberg Bloomberg|Quint is a multiplatform, Indian service and financial news company. We combine Bloombergs global leadership in company and financial news and information, with Quintillion Medias deep competence in the Indian market and digital news delivery, to offer high quality company news, insights and patterns for Indias sophisticated audiences.Customer SupportAmericas +1 212 318 2000 Europe, Middle East, & & Africa +44 20 7330 7500 Asia Pacific +65 6212 1000.